153钐-乙二胺四甲基膦酸以清髓剂量给药，随后对复发的多发性骨髓瘤患者进行第二次自体移植。 - Suppr | 超能文献

153 Samarium-EDTMP in myeloablative dosage followed by a second autotransplantation in patients with relapsed multiple myeloma.

作者信息

Knop Stefan, Dohmen Bernhard M, Kanz Lothar, Bares Roland, Einsele Hermann

机构信息

Dept. of Hematology and Oncology, Tuebingen University Hospital, Tuebingen, German.

出版信息

Haematologica. 2004 Sep;89(9):ECR36.

Abstract

摘要

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

文档翻译

学术文献翻译模型，支持多种主流文档格式。

相似文献

1

153 Samarium-EDTMP in myeloablative dosage followed by a second autotransplantation in patients with relapsed multiple myeloma.

Haematologica. 2004 Sep;89(9):ECR36.

2

A Phase II study of (153)Sm-EDTMP and high-dose melphalan as a peripheral blood stem cell conditioning regimen in patients with multiple myeloma.

Am J Hematol. 2010 Jun;85(6):409-13. doi: 10.1002/ajh.21696.

3

Outcome of myeloablative allogeneic stem cell transplantation in multiple myeloma with a 153Sm-EDTMP-based preparative regimen.

Leukemia. 2005 May;19(5):879-80. doi: 10.1038/sj.leu.2403698.

4

Complete remission after myeloablation with bone-seeking 186Re-HEDP and high-dose melphalan followed by autologous stem cell transplantation in a patient with chemorefractory multiple myeloma.

Bone Marrow Transplant. 2005 Jul;36(1):89-90. doi: 10.1038/sj.bmt.1705002.

5

A phase I study of 153Sm-EDTMP with fixed high-dose melphalan as a peripheral blood stem cell conditioning regimen in patients with multiple myeloma.

Leukemia. 2005 Jan;19(1):118-25. doi: 10.1038/sj.leu.2403575.

6

Quantifying the radiation dosage to individual skeletal lesions treated with samarium-153-EDTMP.

J Nucl Med. 1998 Dec;39(12):2110-5.

7

[Inhibitory effect of samarium-153-labeled ethylenediaminetetramethylene phosphonate (EDTMP) on bone invasion and osteolysis in Walker 256 carcinoma bearing rats].

Zhonghua Zhong Liu Za Zhi. 1997 Nov;19(6):423-6.

8

Samarium-153-EDTMP dosimetry.

J Nucl Med. 1994 Jan;35(1):191-2.

9

Successful treatment of POEMS syndrome with autologous hematopoietic progenitor cell transplantation.

Bone Marrow Transplant. 2001 Aug;28(3):305-9. doi: 10.1038/sj.bmt.1703108.

10

Radiopharmaceutical therapy of 5T33 murine myeloma by sequential treatment with samarium-153 ethylenediaminetetramethylene phosphonate, melphalan, and bone marrow transplantation.

J Natl Cancer Inst. 1993 Sep 15;85(18):1508-13. doi: 10.1093/jnci/85.18.1508.

引用本文的文献

1

Clinical benefit of bone-targeted radiometabolic therapy with 153Sm-EDTMP combined with chemotherapy in patients with metastatic hormone-refractory prostate cancer.

Eur J Nucl Med Mol Imaging. 2007 Jul;34(7):1023-30. doi: 10.1007/s00259-006-0343-8. Epub 2007 Jan 23.

2

Synergistic activity of the proteasome inhibitor PS-341 with non-myeloablative 153-Sm-EDTMP skeletally targeted radiotherapy in an orthotopic model of multiple myeloma.

Blood. 2006 May 15;107(10):4063-70. doi: 10.1182/blood-2005-09-3870. Epub 2006 Jan 19.